ArticleIndian journal of endocrinology and metabolism
Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study).
Mohammad Saifuddin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.